Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases
Proteins: Structure, Function, and Bioinformatics · 2024
DOI: 10.1002/prot.26685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proteins: Structure, Function, and Bioinformatics, 2024. Verfasst von Jyoti Verma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire, USA. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Thermodynamics, Protein Kinase Inhibitors, Receptor, IGF Type 1. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NSF EPSCoR, National Institute of Health (NIH).
Abstract (Originalsprache)
Understanding kinase‐inhibitor selectivity continues to be a major objective in kinase drug discovery. We probe the molecular basis of selectivity of an allosteric inhibitor (MSC1609119A‐1) of the insulin‐like growth factor‐I receptor kinase (IGF1RK), which has been shown to be ineffective for the homologous insulin receptor kinase (IRK). Specifically, we investigated the structural and energetic basis of the allosteric binding of this inhibitor to each kinase by combining molecular modeling, molecular dynamics (MD) simulations, and thermodynamic calculations. We predict the inhibitor conformation in the binding pocket of IRK and highlight that the charged residues in the histidine‐arginine‐aspartic acid (HRD) and aspartic acid‐phenylalanine‐glycine (DFG) motifs and the nonpolar residues in the binding pocket govern inhibitor interactions in the allosteric pocket of each kinase. We suggest that the conformational changes in the IGF1RK residues M1054 and M1079, movement of the ⍺C‐helix, and the conformational stabilization of the DFG motif favor the selectivity of the inhibitor toward IGF1RK. Our thermodynamic calculations reveal that the observed selectivity can be rationalized through differences observed in the electrostatic interaction energy of the inhibitor in each inhibitor/kinase complex and the hydrogen bonding interactions of the inhibitor with the residue V1063 in IGF1RK that are not attained with the corresponding residue V1060 in IRK. Overall, our study provides a rationale for the molecular basis of recognition of this allosteric inhibitor by IGF1RK and IRK, which is potentially useful in developing novel inhibitors with improved affinity and selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire, USA.
- Department of Chemistry, University of New Hampshire, Durham, New Hampshire, USA.
- Integrated Applied Mathematics Program, University of New Hampshire, Durham, New Hampshire, USA.
- Molecular and Cellular Biotechnology Program, University of New Hampshire, Durham, New Hampshire, USA.
ORCID-Profile: Harish Vashisth
Förderung
- NIGMS NIH HHS
- NSF EPSCoR
- National Institute of Health (NIH)
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Verma, J., & Vashisth, H. (2024). Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26685
Vancouver
Verma J, Vashisth H. Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases. Proteins: Structure, Function, and Bioinformatics. 2024. doi:10.1002/prot.26685
BibTeX
@article{Verma2024,
author = {Verma, Jyoti and Vashisth, Harish},
title = {Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2024},
doi = {10.1002/prot.26685}
}
EUVIMED